Effects of iron loading on pathogenicity in hepatitis C virus-infected chimpanzees

Hepatology

Volumn 29, Issue 6, 1999, Pages 1884-1892

  Bassett, S E ^a   Di Bisceglie, A M ^a   Bacon, B R ^a   Sharp, R M ^a   Govindarajan, S ^a   Hubbard, G B ^a   Brasky, K M ^a   Lanford, R E ^a  

^a SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; FERRITIN; IRON;

ANIMAL TISSUE; ARTICLE; CHIMPANZEE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HOST SUSCEPTIBILITY; IRON BLOOD LEVEL; IRON OVERLOAD; LIVER INJURY; NONHUMAN; PRIORITY JOURNAL; VIRUS LOAD; VIRUS PATHOGENESIS;

EID: 0032997087     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510290623     Document Type: Article

References (37)

1. 1 National Institutes of Health. National Institutes of Health Consensus development conference panel statement: management of hepatitis C. Hepatology 1997 ; 26 (Suppl 1): 2S–10S. MEDLINE
2. 2 Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, Hu PY, et al. The natural history of community‐acquired hepatitis C in the United States. N Engl J Med 1992 ; 327: 1899–1905. MEDLINE
3. 3 Alter HJ. To C or not to C: these are the questions. The Journal of the American Society of Hematology 1995 ; 85: 1681–1695.
4. 4 Alter MJ. Epidemiology of hepatitis C in the west. Semin Liver Dis 1995 ; 15: 5–14. MEDLINE
5. 5 Bonkovsky H, Banner BF, Rothman AL. Iron and chronic viral hepatitis. Hepatology 1997 ; 25: 759–768. MEDLINE
6. 6 Di Bisceglie AM, Axiotis CA, Hoofnagle JH, Bacon BR. Measurements of iron status in patients with chronic hepatitis. Gastroenterology 1992 ; 102: 2108–2113. MEDLINE
7. 7 Haque S, Chandra B, Gerber MA, Lok ASF. Iron overload in patients with chronic hepatitis C: a clinicopathologic study. Hum Pathol 1996 ; 27: 1277–1281. MEDLINE
8. 8 Riggio O, Montagnese F, Fiore P, Folino S, Giambartolomei S, Gandin C, Merli M, et al. Iron overload in patients with chronic viral hepatitis: how common is it? Am J Gastroenterol 1997 ; 92: 1298–1301. MEDLINE
9. 9 Arber N, Konikoff FM, Moshkowitz M, Baratz M, Hallak A, Santo M, Halpern Z, et al. Increased serum iron and iron saturation without liver iron accumulation distinguish chronic hepatitis C virus from other chronic liver diseases. Dig Dis Sci 1994 ; 39: 2656–2659. MEDLINE
10. 10 Caramelo C, Albalate M, Bermejillo T, Navas S, Ortiz A, de Sequera P, Casado S, et al. Relationships between plasma ferritin and aminotransferase profile in haemodialysis patients with hepatitis C virus. Nephrol Dial Transplant 1996 ; 11: 1792–1796. MEDLINE
11. 11 Olynyk JK, Reddy KR, Di Bisceglie AM, Jeffers LJ, Parker TI, Radick JL, Schiff ER, et al. Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C. Gastroenterology 1995 ; 108: 1104–1109. MEDLINE
12. 12 Van Thiel DH, Friedlander L, Faginoli S, Wright HI, Irish W, Gavaler JS. Response to interferon alpha‐therapy is influenced by the iron content of the liver. J Hepatol 1994 ; 20: 410–415. MEDLINE
13. 13 Arber N, Moshkowitz M, Konikoff F, Halpern Z, Hallak A, Santo M, Tiomny E, et al. Elevated serum iron predicts poor response to interferon treatment in patients with chronic HCV infection. Dig Dis Sci 1995 ; 40: 2431–2433. MEDLINE
14. 14 Kageyama F, Kobayashi Y, Murohisa G, Shimizu E, Suzuki F, Kikuyama M, Souda K, et al. Failure to respond to interferon‐α2a therapy is associated with increased hepatic iron levels in patients with chronic hepatitis C. Biol Trace Elem Res 1998 ; 64: 185–196. MEDLINE
15. 15 Tsai NCS, Zuckerman E, Han SH, Goad K, Redeker AG, Fong TL. Effect of iron depletion on long‐term response to interferon‐α in patients with chronic hepatitis C who previously did not respond to interferon therapy. Am J Gastroenterol 1997 ; 92: 1831–1834. MEDLINE
16. 16 Piperno A, Sampietro M, D'Alba R, Roffi L, Fargion S, Parma S, Nicoli C, et al. Iron stores, response to alpha‐interferon therapy, and effects of iron depletion in chronic hepatitis C. Liver 1996 ; 16: 248–254. MEDLINE
17. 17 Ikura Y, Morimoto H, Johmura H, Fukui M, Sakurai M. Relationship between hepatic iron deposits and response to interferon in chronic hepatitis C. Am J Gastroenterol 1996 ; 91: 1367–1373. MEDLINE
18. 18 Boucher E, Bourienne A, Adams P, Turlin B, Brissot P, Deugnier Y. Liver iron concentration and distribution in chronic hepatitis C before and after interferon treatment. Gut 1997 ; 41: 115–120. MEDLINE
19. 19 Akiyoshi F, Sata M, Uchimura Y, Suzuki H, Tanikawa K. Hepatic iron stainings in chronic hepatitis C patients with low HCV RNA levels: a predictive marker for IFN therapy. Am J Gastroenterol 1997 ; 92: 1463–1466. MEDLINE
20. 20 Hayashi H, Takikawa T, Nishimura N, Yano M, Isomura T, Sakamoto N. Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron. Am J Gastroenterol 1994 ; 89: 986–988. MEDLINE
21. 21 Hayashi H, Takikawa T, Nishimura N, Yano M. Serum aminotransferase levels as an indicator of the effectiveness of venesection for chronic hepatitis C. J Hepatol 1995 ; 22: 268–271. MEDLINE
22. 22 Fong TL, Han SH, Tsai NC, Morgan TR, Mizokami M, Qian DJ, Phan C, et al. A pilot randomized, controlled trial of the effect of iron depletion on long‐term response to α‐interferon in patients with chronic hepatitis C. J Hepatol 1998 ; 28: 369–374. MEDLINE
23. 23 Bacon BR, Rebholz AE, Fried M, Di Bisceglie AM. Beneficial effect of iron reduction therapy in patients with chronic hepatitis C who failed to respond to interferon‐alpha. Hepatology 1993 ; 18: 90A.
24. 24 Bassett SE, Brasky KM, Lanford RE. Analysis of hepatitis C virus–inoculated chimpanzees reveals unexpected clinical profiles. J Virol 1998 ; 72: 2589–2599. MEDLINE
25. 25 Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981 ; 1: 431–435. MEDLINE
26. 26 Lanford RE, Sureau C, Jacob JR, White R, Fuerst TR. Demonstration of in vitro infection of chimpanzee hepatocytes with hepatitis C virus using strand‐specific RT/PCR. Virology 1994 ; 202: 606–614. MEDLINE
27. 27 Lanford RE, Chavez D, Chisari F, Sureau C. Lack of detection of negative‐strand hepatitis C virus RNA in peripheral blood mononuclear cells and other extrahepatic tissues by the highly strand‐specific rTth reverse transcriptase PCR. J Virol 1995 ; 69: 8079–8083. MEDLINE
28. 28 Lanford RE, Chavez D. Strand specific rTth RT/PCR for the analysis of HCV replication. In: Lau JYN, ed. Methods in Molecular Medicine: Hepatitis C. Totowa, NJ: Humana Press, Inc., 1998 ; 471–482.
29. 29 Olynyk JK, O'Neill R, Britton RS, Bacon BR. Determination of hepatic iron concentration in fresh and paraffin‐embedded tissue: diagnostic implications. Gastroenterology 1994 ; 106: 674–677. MEDLINE
30. 30 Torrance JD, Bothwell TH. A simple technique for measuring storage iron concentrations in formalinized liver samples. S Afr J Med Sci 1968 ; 33: 9–11. MEDLINE
31. 31 Bacon BR, Tavill AS, Brittenham GM, Park CH, Recknagel RO. Hepatic lipid peroxidation in vivo in rats with chronic iron overload. J Clin Invest 1983 ; 71: 429–439. MEDLINE
32. 32 Farinati F, Cardin R, De Maria N, Della Libera G, Marafin C, Lecis E, Burra P, et al. Iron storage, lipid peroxidation and glutathione turnover in chronic anti‐HCV positive hepatitis. J Hepatol 1995 ; 22: 449–456. MEDLINE
33. 33 Puoti C, Magrini A, Stati T, Rigato P, Montagnese F, Rossi P, Aldegheri L, et al. Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels. Hepatology 1997 ; 26: 1393–1398. MEDLINE
34. 34 Silverman AL, Piquette DL, Filipiak CL, Neill JS, Bayati N, Gordon SC. Alfa interferon treatment of hepatitis C virus RNA‐positive patients with normal or near‐normal alanine aminotransferase levels. Am J Gastroenterol 1997 ; 92: 1793–1795. MEDLINE
35. 35 Shakil AO, Conry‐Cantilena C, Alter HJ, Hayashi P, Kleiner DE, Tedeschi V, Krawczynski K, et al. Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. Ann Intern Med 1995 ; 123: 330–337. MEDLINE
36. 36 Piperno A, Fargion S, D'Alba R, Roffi L, Fracanzani L, Vecchi M, Failla M, et al. Liver damage in Italian patients with hereditary hemochromatosis is highly influenced by hepatitis B and C virus infection. J Hepatol 1992 ; 16: 364–368. MEDLINE
37. 37 Weinberg ED. Iron, infection and neoplasia. Clin Physiol Biochem 1986 ; 4: 50–60. MEDLINE